triumeq pd

Generic: abacavir sulfate, dolutegravir sodium, lamivudine

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name triumeq pd
Generic Name abacavir sulfate, dolutegravir sodium, lamivudine
Labeler viiv healthcare company
Dosage Form KIT
Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-258
Product ID 49702-258_4018a8c7-db0d-481e-b50a-a469ba32ec4b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215413
Listing Expiration 2027-12-31
Marketing Start 2022-03-30

Pharmacologic Class

Established (EPC)
hepatitis b virus nucleoside analog reverse transcriptase inhibitor [epc] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702258
Hyphenated Format 49702-258

Supplemental Identifiers

RxCUI
1546888 1546894 2598348 2598352
UPC
0349702231139
UNII
J220T4J9Q2 1Q1V9V5WYQ 2T8Q726O95
NUI
N0000175656 N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name triumeq pd (source: ndc)
Generic Name abacavir sulfate, dolutegravir sodium, lamivudine (source: ndc)
Application Number NDA215413 (source: ndc)
Routes
oral
source: label

Resolved Composition

Strengths
  • 600 mg
  • 50 mg
  • 300 mg
  • 60 mg
  • 5 mg
  • 30 mg
source: label
Packaging
  • 1 KIT in 1 CARTON (49702-258-37) * 90 TABLET, FILM COATED in 1 BOTTLE (49702-272-59)
source: ndc

Packages (1)

49702-258-37 1 KIT in 1 CARTON (49702-258-37) * 90 TABLET, FILM COATED in 1 BOTTLE (49702-272-59)

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Triumeq, Triumeq PD ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "4018a8c7-db0d-481e-b50a-a469ba32ec4b", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0349702231139"], "unii": ["J220T4J9Q2", "1Q1V9V5WYQ", "2T8Q726O95"], "rxcui": ["1546888", "1546894", "2598348", "2598352"], "spl_set_id": ["2997739a-aa91-42aa-a206-a70e2db7b84f"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (49702-258-37)  *  90 TABLET, FILM COATED in 1 BOTTLE (49702-272-59)", "package_ndc": "49702-258-37", "marketing_start_date": "20220330"}], "brand_name": "Triumeq PD", "product_id": "49702-258_4018a8c7-db0d-481e-b50a-a469ba32ec4b", "dosage_form": "KIT", "product_ndc": "49702-258", "generic_name": "abacavir sulfate, dolutegravir sodium, lamivudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triumeq PD", "application_number": "NDA215413", "marketing_category": "NDA", "marketing_start_date": "20220330", "listing_expiration_date": "20271231"}